Tonix Pharmaceuticals Holding Corp (TNXP)
0.1835
+0.01
(+7.25%)
USD |
NASDAQ |
May 03, 16:00
0.1723
-0.01
(-6.10%)
After-Hours: 20:00
Tonix Pharmaceuticals Accounts Payable (Quarterly): 3.782M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.782M |
September 30, 2023 | 7.799M |
June 30, 2023 | 7.673M |
March 31, 2023 | 8.016M |
December 31, 2022 | 8.068M |
September 30, 2022 | 4.556M |
June 30, 2022 | 9.568M |
March 31, 2022 | 9.397M |
December 31, 2021 | 13.28M |
September 30, 2021 | 7.964M |
June 30, 2021 | 3.406M |
March 31, 2021 | 2.859M |
December 31, 2020 | 4.598M |
September 30, 2020 | 1.77M |
June 30, 2020 | 3.189M |
March 31, 2020 | 1.408M |
December 31, 2019 | 3.07M |
September 30, 2019 | 1.119M |
June 30, 2019 | 1.044M |
March 31, 2019 | 1.133M |
December 31, 2018 | 1.404M |
September 30, 2018 | 1.051M |
June 30, 2018 | 1.64M |
March 31, 2018 | 1.264M |
December 31, 2017 | 1.296M |
Date | Value |
---|---|
September 30, 2017 | 1.362M |
June 30, 2017 | 1.179M |
March 31, 2017 | 0.841M |
December 31, 2016 | 0.872M |
September 30, 2016 | 0.944M |
June 30, 2016 | 1.935M |
March 31, 2016 | 2.067M |
December 31, 2015 | 3.049M |
September 30, 2015 | 2.422M |
June 30, 2015 | 2.77M |
March 31, 2015 | 1.986M |
December 31, 2014 | 1.487M |
September 30, 2014 | 2.448M |
June 30, 2014 | 1.518M |
March 31, 2014 | 1.399M |
December 31, 2013 | 0.765M |
September 30, 2013 | 0.9858M |
June 30, 2013 | 1.461M |
March 31, 2013 | 0.8701M |
December 31, 2012 | 0.825M |
September 30, 2012 | 0.6974M |
June 30, 2012 | 0.4869M |
March 31, 2012 | 0.1824M |
December 31, 2011 | 0.6952M |
September 30, 2011 | 0.0052M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.044M
Minimum
Jun 2019
13.28M
Maximum
Dec 2021
5.398M
Average
4.556M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
PetVivo Holdings Inc | 1.094M |
Acurx Pharmaceuticals Inc | -- |
Kezar Life Sciences Inc | 8.251M |
Allakos Inc | 1.764M |
RAPT Therapeutics Inc | 5.176M |